The Patient Perspective – Avenues to Better Success in Late Phase Clinical Studies and Validated Patient Data9:00 – 10:00 a.m. – Room Beacon DPresenter: Uri BaruchPresentation Area: FormulationDiscussion on how the use of technology can assist in ensuring greater patient adherence in phase 2 and 3 clinical trials and how the data gathered during the trial can be used to design better devices as well as medication regime.Company website: www.cambridge-design.co.uk

How to Better Control Pellet Production Processes Through Counting10:30 – 11:30 a.m. – Room Beacon FPresenter: Yosi ShiloniPresentation Areas: Formulation, Quality & Analytical, ProcessingDrug developers and capsule producers are facing a great challenge: how to better control the required active material that is used during the pellet coating process. For answering this challenge, DATA developed a unique solution (DATA Count PH-JR) that quickly and accurately counts pharmaceutical pellets and mini-tablets as small as 0.25 mm.Company website: www.data-technologies.com

The Role Liposomes, Nanoparticles, and Microparticles Play in Parenteral Drug Delivery and Patient Care10:30 – 11:30 a.m. – Room Beacon DPresenters: Thomas Tice and Norbert MaurerPresentation Area: FormulationComplex parenteral formulations include liposomes, nanoparticles, and extended-release microparticles. Established formulation techniques will play key roles in the future delivery of drugs and vaccines based on peptides, proteins, and nucleic acids. They will facilitate newer therapeutic approaches including immunotherapies, gene silencing, and local and targeted delivery. This presentation reviews liposome, nanoparticle, and microparticle based drug delivery approaches and their future impact on patients and healthcare providers.Company website: www.evonik.com/healthcare